Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,309,968
+$2,522,998 QoQ
Shares Held
318,314
+6.7% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,309,968 | 318,314 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $1,786,970 | 298,326 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $2,004,571 | 279,578 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $3,421,302 | 320,347 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $3,224,860 | 333,147 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $5,457,151 | 366,498 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $5,595,115 | 375,008 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $12,115,597 | 633,330 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $14,178,606 | 684,957 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $12,267,691 | 652,537 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $12,465,553 | 864,463 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $21,458,655 | 1,236,098 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $28,839,033 | 1,385,826 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $16,242,225 | 690,571 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $27,978,652 | 1,001,867 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $50,145,773 | 2,142,982 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $76,664,402 | 2,271,538 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $64,174,995 | 1,837,246 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $101,582,958 | 3,336,058 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $106,324,093 | 3,242,577 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $114,586,685 | 3,786,738 | Shares | Other | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||